Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide vs Levetiracetam for Cognition in AD with Epilepsy
NCT05969054Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jul 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lacosamide in Alzheimer's disease (AD), epilepsy, sponsored by Xiangya Hospital, Central South University. Started Jul 2023; status: recruiting.
02
Drugs
lacosamide
03
Conditions
Alzheimer's disease (AD)epilepsy
Beyond the preview
Go deeper on NCT05969054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05969054.